Consequently, the TNF-α/IFN-γ-induced HaCaT cell line, which presents a mixed chronic and aggravated status of AD, was used to evaluate the efficacy of functional foods or drugs [12,24]. This evidence concerns the gene TNF and Alzheimer disease.